mibefradil has been researched along with Cardiac Remodeling, Ventricular in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bitterling, H; Cleutjens, J; Daemen, MJ; Dorenkamp, M; Penz, S; Reinecke, A; Simon, R; Storz, C; Unger, T; Xia, QG | 1 |
Bohle, RM; Dreyer, T; Sandmann, S; Unger, T | 1 |
Claas, R; Cleutjens, JP; Daemen, MJ; Sandmann, S; Unger, T | 1 |
Dumont, L; Jasmin, G; Massicotte, J; Villame, J | 1 |
4 other study(ies) available for mibefradil and Cardiac Remodeling, Ventricular
Article | Year |
---|---|
Comparison of cardioprotective effects of mibefradil and ramipril in stroke-prone spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Calcium Channel Blockers; Cardiotonic Agents; Heart; Heart Rate; Mibefradil; Myocardial Infarction; Organ Size; Ramipril; Rats; Rats, Inbred SHR; Ventricular Pressure; Ventricular Remodeling | 2004 |
The T-type calcium channel blocker mibefradil reduced interstitial and perivascular fibrosis and improved hemodynamic parameters in myocardial infarction-induced cardiac failure in rats.
Topics: Animals; Calcium Channel Blockers; Disease Models, Animal; Fibrosis; Heart; Heart Failure; Hemodynamics; Male; Mibefradil; Myocardial Infarction; Myocardium; Organ Size; Rats; Rats, Wistar; Ventricular Remodeling | 2000 |
Calcium channel blockade limits cardiac remodeling and improves cardiac function in myocardial infarction-induced heart failure in rats.
Topics: Amlodipine; Animals; Calcium Channel Blockers; Heart Failure; Hemodynamics; Hypertrophy, Left Ventricular; Male; Mibefradil; Myocardial Infarction; Myocardium; Rats; Rats, Wistar; Ventricular Remodeling; Verapamil | 2001 |
Effects of mibefradil, a T- and L-type calcium channel blocker, on cardiac remodeling in the UM-X7.1 cardiomyopathic hamster.
Topics: Animals; Body Weight; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Capillaries; Cardiomyopathies; Cricetinae; Heart Failure; Mesocricetus; Mibefradil; Myocardium; Organ Size; Ventricular Remodeling | 2001 |